Thursday, November 21, 2024
11/21/2024
Meta House's Medication for Opioid Recovery and Engagement (MORE) program will provide medications for opioid use disorder (MOUD), substance use disorder and co-occurring mental health disorder treatment, recovery support services, peer support services, and overdose prevention for a diverse population of women with opioid use disorders. The geographic catchment area is southeastern Wisconsin, focused on Milwaukee County. Based on recent Meta House client data and community demographics, we expect to serve a population that is English-speaking and racially diverse, approximately 50% White, 30% Black/African American, 10% Native American, and 10% multiracial/other. Ethnically, we expect our population to be approximately 15% Hispanic/Latinx. Most clients will be 20 to 44 years old. Based on past data, we expect that 85% of the clients served will be heterosexual, 10% bisexual, and 5% lesbian. Meta House's programs are welcoming to transgender clients, although typically transgender women make up only about 1% of our client population. Families served by MORE will be low-income (90% of clients have incomes below the federal poverty level) and have multiple special needs in addition to their opioid use disorders and co-occurring mental health disorders, such as other substance use disorders, unstable housing, trauma histories, low literacy, and employability concerns. A substantial number of women served will be parenting minor children. Most will be involved in multiple systems, including child welfare, TANF, and criminal justice. Meta House, a treatment provider with over 50 years of experience serving the population of focus, will integrate MOUD into substance use disorder treatment for women with opioid use disorders and co-occurring mental health disorders, provide peer and recovery support services, and implement overdose prevention strategies for women across Meta House's continuum of care. The MORE program will integrate the following evidence-based practices into our continuum of care to support recovery for women with opioid use disorders: 1) Motivational Interviewing for treating opioid use disorders, substance use disorders, and co-occurring mental health disorders; 2) Seeking Safety for treating opioid use disorders/substance use disorders and trauma; 3) Peer Recovery Support Services for recovery support and engagement; and 4) Naloxone and Fentanyl Test Strip Distribution for harm reduction and overdose prevention. The goals of the MORE program are to 1) increase Meta House's capacity to provide MOUD through hiring Nurse Practitioners and collaborating with a newly established Opioid Treatment Program, 2) increase the number of individuals with opioid use disorders receiving MOUD, serving 250 women over the five-year grant (30 in Year 1, 40 in Year 2, 50 in Year 3, 60 in Year 4, and 70 in Year 5); 3) provide screening, assessment, treatment planning, and services to support long-term recovery from substance use disorders and co-occurring mental health disorders; 4) decrease misuse of opioids and other substances and provide harm reduction services for overdose prevention; 5) improve women's level of functioning related to mental health and trauma symptoms; and 6) improve access to MOUD for diverse populations. In collaboration with IMPACT, the experienced external evaluator for the project, a program evaluation will be implemented that will measure how the project meets all program goals and objectives as well as additional process evaluation questions and will collect and report data on all required performance measures. GPRA and local evaluation data will be collected in interviews at intake, discharge, 6 months post-intake, and 12 months post-intake.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
